ID

6281

Beschreibung

GOG-0262: Cycle Dose Drug Form (D2R) Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Link

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Stichworte

  1. 18.12.14 18.12.14 - Martin Dugas
  2. 22.08.15 22.08.15 - Martin Dugas
Hochgeladen am

18. Dezember 2014

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0 Legacy

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

GOG-0262: Cycle Dose Drug Form (D2R) - 2917656v1.0

No Instruction available.

  1. StudyEvent: SE.0000
    1. No Instruction available.
Header Module
Beschreibung

Header Module

Date form originally completed (m d y)
Beschreibung

FormOriginalCompleteDate

Datentyp

date

Date form amended (m d y)
Beschreibung

FormAmendedCompleteDate

Datentyp

date

Person amending form, last name
Beschreibung

ResponsiblePersonReportingChangeLastName

Datentyp

text

Patient Initials (First, Middle, Last)
Beschreibung

PatientInitialsName

Datentyp

text

Patient Study ID
Beschreibung

PatientGynecologicOncologyGroupIdentifierNumber

Datentyp

text

Person Completing Form, Last Name
Beschreibung

ResponsiblePersonLastName

Datentyp

text

Treatment Cycle And Modification
Beschreibung

Treatment Cycle And Modification

Current Cycle Number
Beschreibung

TreatmentCurrentCourseNumber

Datentyp

double

Cycle Delayed?
Beschreibung

TreatmentDelayedCycleInd-3

Datentyp

text

Number of days treatment cycle was delayed
Beschreibung

TreatmentDelayDayCount

Datentyp

double

Cycle delayed reason
Beschreibung

TreatmentDelayedCycleReason

Datentyp

text

Cycle start date (Day 1 m d y)
Beschreibung

TreatmentCourseBeginDate

Datentyp

date

Agent name (Drug)
Beschreibung

AgentName

Datentyp

text

Agent Dose level (e.g. mg/m^2)
Beschreibung

AgentDoseLevelValue

Datentyp

text

Were there any dose modifications or additions/omissions to protocol treatment (1=Yes, planned; 2 =Yes, unplanned; 3=No)
Beschreibung

DoseModificationInd

Datentyp

text

Total dose of agents/drugs for this cycle
Beschreibung

AgentCourseTotalDose

Datentyp

double

Units (eg. mg, kg)
Beschreibung

AgentDoseUOM

Datentyp

text

Patient weight (kg)
Beschreibung

PatientWeightMeasurement

Datentyp

double

Maßeinheiten
  • Kg
Kg
Body Surface Area (m^2)
Beschreibung

PersonBodySurfaceAreaValue

Datentyp

double

Maßeinheiten
  • m2
m2
Performance status (Zubrod)
Beschreibung

PerformanceStatusAssessmentEasternCooperativeOncologyGroupScale

Datentyp

text

Pretreatment Hematology And Chemistry Values
Beschreibung

Pretreatment Hematology And Chemistry Values

Assessment Date (m d y)
Beschreibung

LesionAssessmentDate

Datentyp

date

Hemoglobin
Beschreibung

LaboratoryProcedureHemoglobinResultSpecifiedValue

Datentyp

double

Maßeinheiten
  • g/dL
g/dL
Peripheral Hematocrit Count (1000/L)
Beschreibung

LaboratoryProcedureErythrocyteResultCount

Datentyp

double

Peripheral WBC Count (mm3)
Beschreibung

LaboratoryProcedureLeukocyteResultSpecifiedValue

Datentyp

double

Maßeinheiten
  • 1000/uL
1000/uL
Peripheral Granulocytes Count (mm3)
Beschreibung

LaboratoryProcedureGranulocyteResultCount

Datentyp

double

Maßeinheiten
  • 1000/uL
1000/uL
Peripheral Platelet Count (mm3)
Beschreibung

LaboratoryProcedurePlateletResultSpecifiedValue

Datentyp

double

Maßeinheiten
  • 1000/uL
1000/uL
PT (sec)
Beschreibung

LaboratoryProcedureProthrombinTimeResultValue

Datentyp

double

Maßeinheiten
  • seconds
seconds
PTT (sec) (sec)
Beschreibung

LaboratoryProcedurePartialThromboplastinTimeResultValue

Datentyp

double

BUN (mg/dl)
Beschreibung

LaboratoryProcedureBloodUreaNitrogenResultUnspecifiedValue

Datentyp

double

Creatinine (mg/dl)
Beschreibung

LaboratoryProcedureCreatinineResultSpecifiedValue

Datentyp

double

Maßeinheiten
  • mg/dL
mg/dL
Creatinine Clearance (ml/min)
Beschreibung

LaboratoryProcedureCreatinineClearanceOutcomeValue

Datentyp

double

SGOT
Beschreibung

LaboratoryProcedureSerumGlutamicOxaloaceticTransferaseResultUnspecifiedValue

Datentyp

double

Bilirubin
Beschreibung

LaboratoryProcedureTotalBilirubinResultValue

Datentyp

double

Maßeinheiten
  • mg/dL
mg/dL
Alkaline Phosphatase
Beschreibung

LaboratoryProcedureAlkalinePhosphataseResultValue

Datentyp

double

Result of CA125 (IU/ml)
Beschreibung

LaboratoryProcedureCA-125AntigenTumorMarkerResultValue

Datentyp

double

International Normalization Ratio (INR)
Beschreibung

LaboratoryProcedureInternationalNormalizationRatioResultValue

Datentyp

double

Other, specify test
Beschreibung

LaboratoryProcedureSecondOptionalPerformedSpecify

Datentyp

text

Other specify value
Beschreibung

LaboratoryProcedurePerformedValue

Datentyp

double

Comments
Beschreibung

Comments

COMMENTS
Beschreibung

ResearchCommentsText

Datentyp

text

Ähnliche Modelle

No Instruction available.

  1. StudyEvent: SE.0000
    1. No Instruction available.
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Header Module
FormOriginalCompleteDate
Item
Date form originally completed (m d y)
date
FormAmendedCompleteDate
Item
Date form amended (m d y)
date
ResponsiblePersonReportingChangeLastName
Item
Person amending form, last name
text
PatientInitialsName
Item
Patient Initials (First, Middle, Last)
text
PatientGynecologicOncologyGroupIdentifierNumber
Item
Patient Study ID
text
ResponsiblePersonLastName
Item
Person Completing Form, Last Name
text
Item Group
Treatment Cycle And Modification
TreatmentCurrentCourseNumber
Item
Current Cycle Number
double
Item
Cycle Delayed?
text
Code List
Cycle Delayed?
CL Item
No (No)
CL Item
Yes (Yes)
TreatmentDelayDayCount
Item
Number of days treatment cycle was delayed
double
Item
Cycle delayed reason
text
Code List
Cycle delayed reason
CL Item
Non Protocol Illness (Non protocol illness)
CL Item
Patient Refusal (Patient refusal)
CL Item
Personal Reasons (Personal reasons)
CL Item
Protocol Related Ae (Protocol related AE)
CL Item
Scheduling (Scheduling)
TreatmentCourseBeginDate
Item
Cycle start date (Day 1 m d y)
date
AgentName
Item
Agent name (Drug)
text
AgentDoseLevelValue
Item
Agent Dose level (e.g. mg/m^2)
text
Item
Were there any dose modifications or additions/omissions to protocol treatment (1=Yes, planned; 2 =Yes, unplanned; 3=No)
text
Code List
Were there any dose modifications or additions/omissions to protocol treatment (1=Yes, planned; 2 =Yes, unplanned; 3=No)
CL Item
Yes, Planned (i.e., The Treatment Was Changed According To Protocol Guidelines) (Yes, planned)
CL Item
Yes, Unplanned (i.e., The Treatment Change Was Not Part Of Protocol Guidelines) (Yes, unplanned)
CL Item
No (No)
AgentCourseTotalDose
Item
Total dose of agents/drugs for this cycle
double
AgentDoseUOM
Item
Units (eg. mg, kg)
text
PatientWeightMeasurement
Item
Patient weight (kg)
double
PersonBodySurfaceAreaValue
Item
Body Surface Area (m^2)
double
Code List
Performance status (Zubrod)
CL Item
Fully Active, Able To Carry On All Pre-disease Performance Without Restriction. (0)
CL Item
Restricted In Physically Strenuous Activity But Ambulatory And Able To Carry Out Work Of A Light Or Sedentary Nature, E.g., Light Housework, Office Work. (1)
CL Item
Ambulatory And Capable Of All Selfcare But Unable To Carry Out Any Work Activities. Up And About More Than 50% Of Waking Hours. (2)
CL Item
Capable Of Only Limited Selfcare, Confined To Bed Or Chair More Than 50% Of Waking Hours. (3)
CL Item
Completely Disabled. Cannot Carry On Any Selfcare. Totally Confined To Bed Or Chair. (4)
Item Group
Pretreatment Hematology And Chemistry Values
LesionAssessmentDate
Item
Assessment Date (m d y)
date
LaboratoryProcedureHemoglobinResultSpecifiedValue
Item
Hemoglobin
double
LaboratoryProcedureErythrocyteResultCount
Item
Peripheral Hematocrit Count (1000/L)
double
LaboratoryProcedureLeukocyteResultSpecifiedValue
Item
Peripheral WBC Count (mm3)
double
LaboratoryProcedureGranulocyteResultCount
Item
Peripheral Granulocytes Count (mm3)
double
LaboratoryProcedurePlateletResultSpecifiedValue
Item
Peripheral Platelet Count (mm3)
double
LaboratoryProcedureProthrombinTimeResultValue
Item
PT (sec)
double
LaboratoryProcedurePartialThromboplastinTimeResultValue
Item
PTT (sec) (sec)
double
LaboratoryProcedureBloodUreaNitrogenResultUnspecifiedValue
Item
BUN (mg/dl)
double
LaboratoryProcedureCreatinineResultSpecifiedValue
Item
Creatinine (mg/dl)
double
LaboratoryProcedureCreatinineClearanceOutcomeValue
Item
Creatinine Clearance (ml/min)
double
LaboratoryProcedureSerumGlutamicOxaloaceticTransferaseResultUnspecifiedValue
Item
SGOT
double
LaboratoryProcedureTotalBilirubinResultValue
Item
Bilirubin
double
LaboratoryProcedureAlkalinePhosphataseResultValue
Item
Alkaline Phosphatase
double
LaboratoryProcedureCA-125AntigenTumorMarkerResultValue
Item
Result of CA125 (IU/ml)
double
LaboratoryProcedureInternationalNormalizationRatioResultValue
Item
International Normalization Ratio (INR)
double
LaboratoryProcedureSecondOptionalPerformedSpecify
Item
Other, specify test
text
LaboratoryProcedurePerformedValue
Item
Other specify value
double
Item Group
Comments
ResearchCommentsText
Item
COMMENTS
text

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video